Denali Therapeutics (DNLI) Shares Issued (2017 - 2026)
Denali Therapeutics (DNLI) reported Shares Issued of $12.4 million for Q1 2026, up 1978.32% year-over-year from $595000.0 in Q1 2025, and up 46.19% on a QoQ basis from $8.5 million in Q4 2025.
Denali Therapeutics (DNLI) has 10 years of Shares Issued data on file, last reported at $12.4 million in Q1 2026.
- Quarterly Shares Issued rose 1978.32% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (up 19.27% YoY) and the FY2025 annual result came in at $8.5 million, down 51.35% from the prior year.
- Shares Issued grew to $12.4 million in Q1 2026 per DNLI's latest filing, from $8.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $285.2 million in Q4 2022 and bottomed at -$595000.0 in Q2 2025.
- The 5-year median for Shares Issued is $4.9 million (2022), against an average of $25.2 million.
- The widest annual swing landed in 2022, when Shares Issued soared 5418.5%; it then plunged 108.81% in 2025.
- Tracing DNLI's Shares Issued over 5 years: stood at $285.2 million in 2022, then plunged by 98.35% to $4.7 million in 2023, then slipped by 11.69% to $4.2 million in 2024, then surged by 103.59% to $8.5 million in 2025, then surged by 46.19% to $12.4 million in 2026.
- Per Business Quant, the three latest DNLI Shares Issued figures stand at $12.4 million (Q1 2026), $8.5 million (Q4 2025), and -$595000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.37 Mn |
| Mar 31, 2026 | 12.37 Mn |
| Dec 31, 2025 | 8.46 Mn |
| Dec 31, 2025 | 8.46 Mn |
| Jun 30, 2025 | -595,000.00 |
| Jun 30, 2025 | -595,000.00 |
| Mar 31, 2025 | 595,000.00 |
| Mar 31, 2025 | 595,000.00 |
| Dec 31, 2024 | 4.16 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Dec 31, 2022 | 285.20 Mn |
| Dec 31, 2022 | 285.20 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Mar 31, 2021 | 3.82 Mn |
| Mar 31, 2021 | 3.82 Mn |
| Dec 31, 2020 | 182.82 Mn |
| Dec 31, 2020 | 182.82 Mn |
| Sep 30, 2020 | -182.82 Mn |
| Sep 30, 2020 | -182.82 Mn |
| Jun 30, 2020 | 191.98 Mn |
| Jun 30, 2020 | 191.98 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | -908,000.00 |
| Jun 30, 2019 | -908,000.00 |
| Mar 31, 2019 | 908,000.00 |
| Mar 31, 2019 | 908,000.00 |
| Dec 31, 2018 | -2.31 Mn |
| Dec 31, 2018 | -2.31 Mn |
| Sep 30, 2018 | 658,000.00 |
| Sep 30, 2018 | 658,000.00 |
| Jun 30, 2018 | 1.43 Mn |
| Jun 30, 2018 | 1.43 Mn |
| Mar 31, 2018 | 219,000.00 |
| Mar 31, 2018 | 219,000.00 |
| Dec 31, 2017 | 733,000.00 |
| Dec 31, 2017 | 733,000.00 |
| Jun 30, 2017 | -324,000.00 |
| Jun 30, 2017 | -324,000.00 |
| Mar 31, 2017 | 324,000.00 |
| Mar 31, 2017 | 324,000.00 |